Description
Dexlansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the (H+, K+)-ATPase at the secretory surface of the gastric parietal cell. Dexlansoprazole has been characterized as a gastric proton-pump inhibitor, in that it blocks the final step of acid production.
Additional information
| Brand | PharmEvo |
|---|---|
| Form | Oral Capsule |
| Strength | 30MG |
Reviews
There are no reviews yet.